Synovus Financial Corp grew its stake in HCA Holdings, Inc. (NYSE:HCA) by 172.6% during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 2,290 shares of the company’s stock after purchasing an additional 1,450 shares during the quarter. Synovus Financial Corp’s holdings in HCA Holdings were worth $200,000 at the end of the most recent reporting period.
Several other hedge funds also recently bought and sold shares of HCA. Acadian Asset Management LLC lifted its stake in shares of HCA Holdings by 104.5% in the 1st quarter. Acadian Asset Management LLC now owns 7,029 shares of the company’s stock valued at $625,000 after purchasing an additional 3,592 shares during the period. IFP Advisors Inc lifted its stake in shares of HCA Holdings by 9.4% in the 1st quarter. IFP Advisors Inc now owns 1,605 shares of the company’s stock valued at $143,000 after purchasing an additional 138 shares during the period. Capital Fund Management S.A. lifted its stake in shares of HCA Holdings by 79.8% in the 1st quarter. Capital Fund Management S.A. now owns 17,923 shares of the company’s stock valued at $1,595,000 after purchasing an additional 7,957 shares during the period. US Bancorp DE lifted its stake in shares of HCA Holdings by 6.1% in the 1st quarter. US Bancorp DE now owns 20,739 shares of the company’s stock valued at $1,845,000 after purchasing an additional 1,196 shares during the period. Finally, Zurcher Kantonalbank Zurich Cantonalbank lifted its stake in shares of HCA Holdings by 41.6% in the 1st quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 234,800 shares of the company’s stock valued at $20,895,000 after purchasing an additional 69,033 shares during the period. 73.77% of the stock is currently owned by institutional investors.
Shares of HCA Holdings, Inc. (NYSE HCA) opened at 77.05 on Monday. The firm has a market cap of $27.83 billion, a P/E ratio of 10.33 and a beta of 0.67. The firm has a 50 day moving average price of $79.21 and a 200 day moving average price of $83.78. HCA Holdings, Inc. has a 1-year low of $67.00 and a 1-year high of $91.03.
HCA Holdings (NYSE:HCA) last announced its quarterly earnings data on Tuesday, July 25th. The company reported $1.75 earnings per share for the quarter, missing the consensus estimate of $1.80 by $0.05. HCA Holdings had a net margin of 6.64% and a negative return on equity of 48.08%. The company had revenue of $10.73 billion for the quarter, compared to analyst estimates of $10.76 billion. During the same quarter in the prior year, the company posted $1.66 EPS. HCA Holdings’s revenue for the quarter was up 4.0% on a year-over-year basis. Analysts anticipate that HCA Holdings, Inc. will post $7.19 EPS for the current year.
A number of research analysts have recently weighed in on the company. BidaskClub downgraded HCA Holdings from a “sell” rating to a “strong sell” rating in a research note on Saturday, August 5th. Zacks Investment Research downgraded HCA Holdings from a “buy” rating to a “hold” rating in a research note on Friday, July 14th. KeyCorp reissued a “buy” rating and issued a $95.00 price target on shares of HCA Holdings in a research note on Thursday. Citigroup Inc. cut their price target on HCA Holdings from $89.00 to $87.00 and set a “neutral” rating on the stock in a research note on Wednesday, July 26th. Finally, Leerink Swann raised HCA Holdings from a “market perform” rating to an “outperform” rating and increased their price target for the company from $92.00 to $100.00 in a research note on Tuesday, June 6th. One investment analyst has rated the stock with a sell rating, six have assigned a hold rating and twelve have issued a buy rating to the company. The stock has a consensus rating of “Buy” and a consensus target price of $92.88.
COPYRIGHT VIOLATION WARNING: This report was originally published by Sports Perspectives and is the property of of Sports Perspectives. If you are accessing this report on another website, it was copied illegally and republished in violation of U.S. and international copyright and trademark law. The original version of this report can be accessed at https://sportsperspectives.com/2017/09/11/synovus-financial-corp-has-200000-stake-in-hca-holdings-inc-hca.html.
In other news, insider Michael S. Cuffe sold 2,150 shares of the company’s stock in a transaction dated Monday, July 17th. The shares were sold at an average price of $86.44, for a total transaction of $185,846.00. Following the transaction, the insider now owns 12,363 shares in the company, valued at $1,068,657.72. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Jonathan B. Perlin sold 71,063 shares of the company’s stock in a transaction dated Thursday, June 22nd. The shares were sold at an average price of $86.00, for a total transaction of $6,111,418.00. The disclosure for this sale can be found here. Insiders have sold 77,513 shares of company stock worth $6,651,455 in the last quarter. Company insiders own 2.90% of the company’s stock.
HCA Holdings Company Profile
HCA Healthcare, Inc, formerly HCA Holdings, Inc, is a holding company. The Company, through its subsidiaries, owns and operates hospitals and related healthcare entities. As of December 31, 2016, the Company operated in two geographically organized groups, including the National and American Groups. As of December 31, 2016, the National Group included 84 hospitals, which were located in Alaska, California, Florida, southern Georgia, Idaho, Indiana, northern Kentucky, Nevada, New Hampshire, South Carolina, Utah and Virginia.
Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Holdings, Inc. (NYSE:HCA).
Receive News & Ratings for HCA Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.